Steven Syre’s Dec. 11 Boston Capital column (“Mass. biotechs glitter in new golden age,” Business) spoke to the growth in our state’s strong biotech community. This isn’t happening by accident. The Patrick-Murray administration’s 10-year, $1 billion life sciences initiative has significantly affected these innovation economy sectors, and the Massachusetts Life Sciences Center is partnering with industry and academia to enable the life sciences to thrive here.
Syre mentions the promising technologies being developed by young companies; the Life Sciences Center is supporting young companies through direct funding and access to talented interns. Our grants for cooperative research partnerships between industry and academia help accelerate the translation of promising technologies into commercialized products. The center’s capital investments have helped create more than 1 million square feet of new research and biomanufacturing space around the state.
Three of the companies that Syre mentions — Vertex, Ironwood, and Cubist — have participated in the center’s tax incentive program, which encourages life sciences job growth in Massachusetts. Since 2002 employment in the state’s biopharma industry has grown more than 40 percent.
The center’s investments and public-private partnerships are coalescing our life sciences cluster into a fertile system for ongoing growth in this important industry.